OncoSec Medical Inc. (ONCS) Appoints Dr. Anthony E. Maida, III, to Board of Directors
OncoSec Medical Inc., a late-stage biomedical company that designs, develops, and commercializes therapeutic oncology products, recently announced that it has appointed a new member to its Board of Directors, Anthony E. Maida III, Ph.D. Dr. Maida will chair the Company’s audit committee. For more than 20 years, Dr. Maida has focused on the clinical development of immunotherapies for the treatment of cancer in patients. As a chairman, CEO, and senior executive, Dr. Maida has managed and carried out all critical functions, which include finance, research, operations, clinical development, regulatory and manufacturing for biotechnology companies that are in the early in…